2898 — Sunho Biologics Income Statement
0.000.00%
Last trade - 00:00
HealthcareSmall Cap
- HK$968.20m
- HK$1.38bn
2022 December 31st | 2023 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Revenue | ||
Total Revenue | 0 | 0 |
Selling / General / Administrative Expenses | ||
Research And Development | ||
Depreciation and Amortization | ||
Unusual Expense / Income | ||
Other Operating Expenses | ||
Total Operating Expenses | 46.9 | 132 |
Operating Profit | -46.9 | -132 |
Total Net Non Operating Interest Income / Expense | ||
Net Income Before Taxes | -52 | -133 |
Provision for Income Taxes | ||
Net Income After Taxes | -52 | -133 |
Net Income Before Extraordinary Items | ||
Net Income | -52 | -133 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||
Income Available to Common Shareholders Including Extraordinary Items | ||
Diluted Net Income | -52 | -133 |
Diluted Weighted Average Shares | ||
Basic EPS Including Extraordinary Items | ||
Diluted EPS Including Extraordinary Items | ||
Diluted EPS Excluding Extraordinary Items | ||
Normalised Income Before Taxes | ||
Normalised Income After Taxes | ||
Normalised Income Available to Common Shareholders | ||
Diluted Normalised EPS | -0.403 | -0.722 |